Lawson Kroeker Investment Management Inc. NE Has $1.13 Million Holdings in Procter & Gamble Company (The) $PG

Lawson Kroeker Investment Management Inc. NE trimmed its holdings in Procter & Gamble Company (The) (NYSE:PG) by 2.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,105 shares of the company’s stock after selling 165 shares during the period. Lawson Kroeker Investment Management Inc. NE’s holdings in Procter & Gamble were worth $1,132,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of the business. Kingstone Capital Partners Texas LLC raised its holdings in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC bought a new stake in shares of Procter & Gamble during the first quarter worth $1,954,941,000. Price T Rowe Associates Inc. MD raised its stake in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. grew its holdings in shares of Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after buying an additional 2,228,151 shares in the last quarter. Finally, Valeo Financial Advisors LLC raised its position in Procter & Gamble by 1,875.5% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after buying an additional 1,674,139 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Jennifer L. Davis sold 3,227 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the sale, the chief executive officer owned 61,764 shares in the company, valued at approximately $9,402,333.72. This trade represents a 4.97% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the transaction, the chief operating officer owned 46,899 shares in the company, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have recently weighed in on PG. Wells Fargo & Company decreased their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. BNP Paribas reaffirmed an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. JPMorgan Chase & Co. cut their price target on shares of Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research report on Friday. UBS Group decreased their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $172.21.

Procter & Gamble Stock Down 0.6%

Shares of PG stock opened at $149.69 on Friday. Procter & Gamble Company has a 52-week low of $149.45 and a 52-week high of $180.43. The stock has a market cap of $350.34 billion, a price-to-earnings ratio of 22.99, a PEG ratio of 3.97 and a beta of 0.36. The firm’s 50-day moving average is $155.24 and its 200-day moving average is $159.48. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the previous year, the business earned $1.40 earnings per share. The business’s revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.